CLO21-013: Atrial Fibrillation With Ibrutinib Therapy: Potential Pharmacologic Interactors in a Single-Institution Retrospective Study

View More View Less
  • 1 The University of California San Diego Health System, La Jolla, California
  • 2 University of California San Diego, La Jolla, California
  • 3 Moores Cancer Center, University of California, San Diego, La Jolla, CA
Restricted access

Corresponding Author: Mitchell Flagg, BSPH
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 204 204 116
PDF Downloads 370 370 172
EPUB Downloads 0 0 0